Milan - Delayed Quote EUR

Banca Mediolanum S.p.A. (BMED.MI)

Compare
11.37
+0.01
+(0.09%)
At close: December 23 at 5:35:23 PM GMT+1
Loading Chart for BMED.MI
DELL
  • Previous Close 11.36
  • Open 11.26
  • Bid 11.33 x --
  • Ask 11.34 x --
  • Day's Range 11.26 - 11.42
  • 52 Week Range 8.48 - 11.88
  • Volume 1,049,677
  • Avg. Volume 982,257
  • Market Cap (intraday) 8.384B
  • Beta (5Y Monthly) 1.27
  • PE Ratio (TTM) 9.17
  • EPS (TTM) 1.24
  • Earnings Date Feb 6, 2025 - Feb 10, 2025
  • Forward Dividend & Yield 0.74 (6.51%)
  • Ex-Dividend Date Nov 18, 2024
  • 1y Target Est 12.90

Banca Mediolanum S.p.A. provides various banking products and services in Italy. The company offers current accounts; deposits; and mortgages and loans. It also provides debit, credit, and prepaid cards; investment products, such as mutual funds, unit linked policies, investment strategies, other investments, trading, and retirement products; and life insurance products and services. In addition, the company engages in audio and television production business; real estate business; mutual fund and trust management business; and the provision of damage insurance, financial intermediation, and payment services. Banca Mediolanum S.p.A. founded in 1982 and is headquartered in Basiglio, Italy.

www.bancamediolanum.it

3,799

Full Time Employees

December 31

Fiscal Year Ends

Recent News: BMED.MI

View More

Performance Overview: BMED.MI

Trailing total returns as of 12/23/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

BMED.MI
43.55%
FTSE MIB Index
11.16%

1-Year Return

BMED.MI
44.81%
FTSE MIB Index
11.16%

3-Year Return

BMED.MI
62.09%
FTSE MIB Index
25.76%

5-Year Return

BMED.MI
70.24%
FTSE MIB Index
40.56%

Compare To: BMED.MI

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: BMED.MI

View More

Valuation Measures

As of 12/23/2024
  • Market Cap

    8.38B

  • Enterprise Value

    --

  • Trailing P/E

    9.18

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    3.96

  • Price/Book (mrq)

    2.16

  • Enterprise Value/Revenue

    4.10

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    44.19%

  • Return on Assets (ttm)

    1.15%

  • Return on Equity (ttm)

    25.25%

  • Revenue (ttm)

    2.09B

  • Net Income Avi to Common (ttm)

    924.04M

  • Diluted EPS (ttm)

    1.24

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.05B

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: BMED.MI

View More

People Also Watch